Try

Sanara MedTech Inc. Common Stock

SMTIUnited States

5 filed reports · 287 financial concepts · 4 earnings calls · 0 media appearances

Filed reports

5 reports · Jun 2025 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR41,109Jun 2025 to Jun 2026
Annual · 10-KSEC EDGAR1591Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 11, 2026371Open
FY2026 Q110-QMar 31, 2026May 12, 2026245Open
FY202510-KDec 31, 2025Mar 24, 2026591Open
FY2025 Q310-QSep 30, 2025Nov 12, 2025263Open
FY2025 Q210-QJun 30, 2025Aug 13, 2025230Open

Financial data

287 concepts · 1,700 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial270 concepts · 1,630 facts · Mar 2024 to Jun 2026

  • Stockholders equity including portion attributable to noncontrolling interest13 · Mar 2024 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations12 · Jun 2024 to Jun 2026
  • Profit loss12 · Mar 2024 to Jun 2026
  • Stock issued during period value share based compensation12 · Mar 2024 to Jun 2026
  • Amortization of intangible assets11 · Jun 2024 to Jun 2026
  • Cost of revenue (US GAAP)11 · Jun 2024 to Jun 2026
  • Depreciation11 · Jun 2024 to Jun 2026
  • Depreciation and amortization11 · Jun 2024 to Jun 2026
  • Employee benefits and share based compensation noncash11 · Jun 2024 to Jun 2026
  • Gross profit (US GAAP)11 · Jun 2024 to Jun 2026
  • Interest expense (US GAAP)11 · Jun 2024 to Jun 2026
  • Inventory write down11 · Jun 2024 to Jun 2026
  • Net income loss11 · Jun 2024 to Jun 2026
  • Net income loss attributable to noncontrolling interest11 · Jun 2024 to Jun 2026
  • Operating expenses (US GAAP)11 · Jun 2024 to Jun 2026
  • Operating income loss11 · Jun 2024 to Jun 2026
  • Operating lease expense11 · Jun 2024 to Jun 2026
  • Other nonoperating income expense11 · Jun 2024 to Jun 2026
  • Provision for doubtful accounts11 · Jun 2024 to Jun 2026
  • Research and development expense11 · Jun 2024 to Jun 2026
  • Revenue11 · Jun 2024 to Jun 2026
  • Segment Adjusted EBITDA11 · Jun 2024 to Jun 2026
  • Selling general and administrative expense11 · Jun 2024 to Jun 2026
  • Share based compensation11 · Jun 2024 to Jun 2026

Segment16 concepts · 45 facts · Jun 2024 to Dec 2025

  • Business combination acquisition related costs4 · Jun 2024 to Jun 2025
  • Depreciation and amortization4 · Jun 2024 to Jun 2025
  • Employee benefits and share based compensation noncash4 · Jun 2024 to Jun 2025
  • Profit loss4 · Jun 2024 to Jun 2025
  • Research and development expense4 · Jun 2024 to Jun 2025
  • Segment Adjusted EBITDA4 · Jun 2024 to Jun 2025
  • Selling general and administrative expense4 · Jun 2024 to Jun 2025
  • Revenue3 · Jun 2024 to Jun 2025
  • Asset impairment charges2 · Dec 2025
  • Cost of revenue (US GAAP)2 · Jun 2024 to Jun 2025
  • Executive separation costs2 · Jun 2024 to Jun 2025
  • Interest expense (US GAAP)2 · Jun 2024 to Jun 2025
  • Liabilities fair value adjustment2 · Jun 2024
  • Other nonoperating income expense2 · Jun 2024 to Jun 2025
  • Income loss from equity method investments1 · Jun 2025
  • Internal use software costs capitalized1 · Jun 2025

Product1 concepts · 25 facts · Jun 2024 to Jun 2026

  • Revenue25 · Jun 2024 to Jun 2026

Segments

70 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments2 members · 45 facts

  • Sanara Surgical27 · Jun 2024 to Dec 2025
  • THP18 · Jun 2024 to Dec 2025

Product or service4 members · 25 facts

  • Bone Fusion Products11 · Jun 2024 to Jun 2026
  • Soft Tissue Repair Products11 · Jun 2024 to Jun 2026
  • Royalty2 · Jun 2024 to Sep 2024
  • Saa S1 · Jun 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

4 calls · Aug 2025 to May 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q1May 12, 2026
  • FY2025 Q4Mar 24, 2026
  • FY2025 Q3Nov 12, 2025
  • FY2025 Q2Aug 13, 2025

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Sanara MedTech Inc. Common Stock (SMTI) data · FactIQ